Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Text message reminders to patients can improve medication adherence by 15.3 to 17.8 percent, according to findings published in the Journal of Clinical Nursing.
What started as a relatively quiet week in health IT got a jolt with IBM's announcement that it plans on acquiring Merge Healthcare. That wasn't the only interesting development this week. Here are the six most significant
The Food and Drug Administration's Office of Health Informatics has contracted with DNAnexus to create open source cloud-based software for sharing genomic information as part of the Obama administration's precision medicine initiative.
The Food and Drug Administration (FDA) has issued an alert to users of a computerized infusion pump that communicates with hospital information systems via a wired or wireless connection over facility network infrastructures. The pump has serious cybersecurity vulnerabilities that could put patient safety at risk.
The global market for telemedicine will be worth more than $34 billion by the end of 2020, according to the predictions made by Mordor Intelligence in a new market research report.
eHealth Initiatives is holding the iTHRIVE Innovation Challenge next week to convene stakeholders on the topic of how health technology can improve the quality, safety and efficiency of healthcare.
Hospitals’ efforts to reduce readmissions within 30 days of discharge aren’t going very well, according to the latest numbers from the Centers for Medicare & Medicaid Services.
Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.
When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country.
If passed, this bill would help clinician-led clinical registries explore Medicare data for research purposes. The Society of Thoracic Surgeons and American College of Cardiology both shared public support for the bipartisan legislation.